OS Therapies OSTX
NYSE OSTX
$1.29 +0.03 (+2.38%)
As of: Oct 21, 2026 · 3:59 PM EDT

OS Therapies (OSTX) Capital Expenditures (2025)

Updated

OS Therapies' Capital Expenditures was $466,423 in FY2025.

Analysis

OS Therapies (OSTX) Capital Expenditures (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 OS Therapies 6.11 Mn 2.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 316,423.00
Mar 31, 2025 150,000.00
API Access

OS Therapies Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OSTX&period=max&api_key=YOUR_API_KEY